🇺🇸 FDA
Patent

US 12251561

Minimally invasive dermal electroporation device

granted A61KA61K2039/53

Quick answer

US patent 12251561 (Minimally invasive dermal electroporation device) held by Inovio Pharmaceuticals, Inc. expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K2039/53